Congenital Arthrogryposis: An Extension of the 15q11.2 BP1-BP2 Microdeletion Syndrome?

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3978403)

Published in Case Rep Genet on February 12, 2014

Authors

K M Usrey1, C A Williams2, M Dasouki3, L C Fairbrother2, M G Butler1

Author Affiliations

1: Departments of Psychiatry, Behavioral Sciences and Pediatrics, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, KS 66160, USA.
2: Division of Genetics and Metabolism, Department of Pediatrics, University of Florida College of Medicine, Gainesville, FL 32610, USA.
3: Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA ; King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.

Articles citing this

The 15q11.2 BP1-BP2 microdeletion syndrome: a review. Int J Mol Sci (2015) 0.93

Articles cited by this

Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25

Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet (2009) 4.52

Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96

FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med (2001) 3.84

The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell (2008) 3.10

Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med (2005) 2.04

Arthrogryposis: a review and update. J Bone Joint Surg Am (2009) 2.04

Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet (2011) 1.94

Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res (2007) 1.92

Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet (2003) 1.82

Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics (2004) 1.81

Clinical and genetic aspects of Angelman syndrome. Genet Med (2010) 1.74

Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet (2009) 1.60

NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet (2003) 1.54

Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations. Eur J Hum Genet (2007) 1.52

Genetic aspects of arthrogryposis. Clin Orthop Relat Res (1985) 1.46

Prader-Willi Syndrome: Obesity due to Genomic Imprinting. Curr Genomics (2011) 1.43

Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome. Pediatrics (2006) 1.36

NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem (2006) 1.34

Multiple congenital contractures: birth prevalence, etiology, and outcome. J Pediatr (2002) 1.12

Functional characterization of NIPA2, a selective Mg2+ transporter. Am J Physiol Cell Physiol (2008) 0.99

Expanding the BP1-BP2 15q11.2 Microdeletion Phenotype: Tracheoesophageal Fistula and Congenital Cataracts. Case Rep Genet (2013) 0.83